![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 25, 22003-22010, June 22, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Medizinische Universitäts-Poliklinik,
Wilhelmstrasse 35-37, 53111 Bonn, Germany
p21-activated kinase (PAK) has been shown to be
an upstream mediator of JNK in angiotensin II (AngII) signaling. Little
is known regarding other signaling molecules involved in
activation of PAK and JNK by AngII. Rho family GTPases Rac and Cdc42
have been shown to enhance PAK activity by binding to p21-binding
domain of PAK (PAK-PBD). In vascular smooth muscle cells (VSMC) AngII stimulated Rac1 binding to GST-PAK-PBD fusion protein. Pretreatment of
VSMC by genistein inhibited AngII-induced Rac1 activation, whereas Src
inhibitor PP1 had no effect. Inhibition of protein kinase C by phorbol
12,13-dibutyrate pretreatment also decreased AngII-mediated activation
of Rac1. The adaptor molecule Nck has been shown previously to mediate
PAK activation by facilitating translocation of PAK to the plasma
membrane. In VSMC AngII stimulated translocation of Nck and PAK to the
membrane fraction. Overexpression of dominant-negative Nck in Chinese
hamster ovary (CHO) cells, stably expressing the AngII type I receptor
(CHO-AT1), inhibited both PAK and JNK activation by AngII, whereas it
did not affect ERK1/2. Finally, dominant-negative Nck inhibited
AngII-induced DNA synthesis in CHO-AT1 cells. Our data provide evidence
for Rac1 and Nck as upstream mediators of PAK and JNK in AngII
signaling and implicate JNK in AngII-induced growth responses.
Angiotensin II-induced Stimulation of p21-activated Kinase
and c-Jun NH2-terminal Kinase Is Mediated by Rac1 and
Nck*
,
*
This work was supported by the German Research Foundation
Grant SCHM 1174/3-1 (to U. S.) and by the BONFOR Program Grant BONFOR 110/24 (to K. T.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Medizinische
Universitäts-Poliklinik, Wilhelmstrasse 35-37, 53111 Bonn,
Germany. Tel.: 49-228-287-2263; Fax: 49-228-287-2658; E-mail:
uschmitz@uni- bonn.de.
This article has been cited by other articles:
![]() |
R. El Bekay, G. Alba, M E. Reyes, P. Chacon, A. Vega, J. Martin-Nieto, J. Jimenez, E. Ramos, J. Olivan, E. Pintado, et al. Rac2 GTPase activation by angiotensin II is modulated by Ca2+/calcineurin and mitogen-activated protein kinases in human neutrophils J. Mol. Endocrinol., November 1, 2007; 39(5): 351 - 363. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wei, C.-H. Tang, Y. Kim, L. Robillard, F. Zhang, M. C. Kugler, and H. A. Chapman Urokinase Receptors Are Required for {alpha}5beta1 Integrin-mediated Signaling in Tumor Cells J. Biol. Chem., February 9, 2007; 282(6): 3929 - 3939. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Otis and N. Gallo-Payet Differential Involvement of Cytoskeleton and Rho-Guanosine 5'-Triphosphatases in Growth-Promoting Effects of Angiotensin II in Rat Adrenal Glomerulosa Cells Endocrinology, November 1, 2006; 147(11): 5460 - 5469. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ohtsu, H. Suzuki, H. Nakashima, S. Dhobale, G. D. Frank, E. D. Motley, and S. Eguchi Angiotensin II Signal Transduction Through Small GTP-Binding Proteins: Mechanism and Significance in Vascular Smooth Muscle Cells Hypertension, October 1, 2006; 48(4): 534 - 540. [Full Text] [PDF] |
||||
![]() |
S. D. Hingtgen, X. Tian, J. Yang, S. M. Dunlay, A. S. Peek, Y. Wu, R. V. Sharma, J. F. Engelhardt, and R. L. Davisson Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy Physiol Genomics, September 14, 2006; 26(3): 180 - 191. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Woolfolk, S. Eguchi, H. Ohtsu, H. Nakashima, H. Ueno, W. T. Gerthoffer, and E. D. Motley Angiotensin II-induced activation of p21-activated kinase 1 requires Ca2+ and protein kinase C{delta} in vascular smooth muscle cells Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1286 - C1294. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Brown, L. A. Cary, J. S. Jamieson, J. A. Cooper, and C. E. Turner Src and FAK Kinases Cooperate to Phosphorylate Paxillin Kinase Linker, Stimulate Its Focal Adhesion Localization, and Regulate Cell Spreading and Protrusiveness Mol. Biol. Cell, September 1, 2005; 16(9): 4316 - 4328. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Dixon, P. J. White, J. F. Hall, S. Kingston, and M. R. Boarder Regulation of Human Hepatocytes by P2Y Receptors: Control of Glycogen Phosphorylase, Ca2+, and Mitogen-Activated Protein Kinases J. Pharmacol. Exp. Ther., June 1, 2005; 313(3): 1305 - 1313. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nishida, S. Tanabe, Y. Maruyama, S. Mangmool, K. Urayama, Y. Nagamatsu, S. Takagahara, J. H. Turner, T. Kozasa, H. Kobayashi, et al. G{alpha}12/13- and Reactive Oxygen Species-dependent Activation of c-Jun NH2-terminal Kinase and p38 Mitogen-activated Protein Kinase by Angiotensin Receptor Stimulation in Rat Neonatal Cardiomyocytes J. Biol. Chem., May 6, 2005; 280(18): 18434 - 18441. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tsuda, M. Iwai, J.-M. Li, H.-S. Li, L.-J. Min, A. Ide, M. Okumura, J. Suzuki, M. Mogi, H. Suzuki, et al. Inhibitory Effects of AT1 Receptor Blocker, Olmesartan, and Estrogen on Atherosclerosis Via Anti-Oxidative Stress Hypertension, April 1, 2005; 45(4): 545 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Brandes and J. Kreuzer Vascular NADPH oxidases: molecular mechanisms of activation Cardiovasc Res, January 1, 2005; 65(1): 16 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Terebessy, A. Masszi, A. Fintha, A. Sebe, T. Huszar, L. Rosivall, and I. Mucsi Angiotensin II activates the human renin promoter in an in vitro model: the role of c-Jun-N-terminal kinase Nephrol. Dial. Transplant., September 1, 2004; 19(9): 2184 - 2191. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Natarajan, G. Yin, and B. C. Berk Scaffolds Direct Src-Specific Signaling in Response to Angiotensin II: New Roles for Cas and GIT1 Mol. Pharmacol., April 1, 2004; 65(4): 822 - 825. [Full Text] |
||||
![]() |
D. Gregg, F. M. Rauscher, and P. J. Goldschmidt-Clermont Rac regulates cardiovascular superoxide through diverse molecular interactions: more than a binary GTP switch Am J Physiol Cell Physiol, October 1, 2003; 285(4): C723 - C734. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Sundberg, L. M. Galante, H. M. Bill, C. P. Mack, and J. M. Taylor An Endogenous Inhibitor of Focal Adhesion Kinase Blocks Rac1/JNK but Not Ras/ERK-dependent Signaling in Vascular Smooth Muscle Cells J. Biol. Chem., August 8, 2003; 278(32): 29783 - 29791. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Gorin, J. M. Ricono, N.-H. Kim, B. Bhandari, G. G. Choudhury, and H. E. Abboud Nox4 mediates angiotensin II-induced activation of Akt/protein kinase B in mesangial cells Am J Physiol Renal Physiol, August 1, 2003; 285(2): F219 - F229. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Vazquez, C. Sun, J. Du, L. Fuentes, C. Sumners, and M. K. Raizada Transduction of a Functional Domain of the AT1 Receptor in Neurons by HIV-Tat PTD Hypertension, March 1, 2003; 41(3): 751 - 756. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Horiuchi, T.-X. Cui, Z. Li, J.-M. Li, H. Nakagami, and M. Iwai Fluvastatin Enhances the Inhibitory Effects of a Selective Angiotensin II Type 1 Receptor Blocker, Valsartan, on Vascular Neointimal Formation Circulation, January 7, 2003; 107(1): 106 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Brown and N. R. Kamal The Reed-Sternberg Cell: Molecular Characterization by Proteomic Analysis with Therapeutic Implications Ann. Clin. Lab. Sci., October 1, 2002; 32(4): 339 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Murakami, Y. Yamamura, Y. Shimono, K. Kawai, K. Kurokawa, and M. Takahashi Role of Dok1 in Cell Signaling Mediated by RET Tyrosine Kinase J. Biol. Chem., August 30, 2002; 277(36): 32781 - 32790. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ruiz-Velasco, C. C. Lanning, and C. L. Williams The Activation of Rac1 by M3 Muscarinic Acetylcholine Receptors Involves the Translocation of Rac1 and IQGAP1 to Cell Junctions and Changes in the Composition of Protein Complexes Containing Rac1, IQGAP1, and Actin J. Biol. Chem., August 30, 2002; 277(36): 33081 - 33091. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |